Quantification of rigidity and tremor activity in rats by using a new device and its validation by different classes of drugs

Arzneimittel-Forschung/Drug Research

Volumn 47, Issue 10, 1997, Pages 1081-1086

  Nickel, Bernd ^a   Kolasiewicz, Waczek ^b   Szelenyi, Istvan ^a,c  

^a ASTA MEDICA AG   (Germany)

^b INSTITUTE OF PHARMACOLOGY   (Poland)

^c Arzneimittelwerk Dresden GmbH   (Germany)

Author keywords

Anti tremor drugs; Muscle relaxants; Opioids; Rigidity, quantification, rats; Tremor, quantification, rats

Indexed keywords

AMANTADINE; BACLOFEN; BENSERAZIDE PLUS LEVODOPA; BENZODIAZEPINE DERIVATIVE; BROMOCRIPTINE; CODEINE; DANTROLENE; DIAZEPAM; LEVODOPA; MEPHENESIN; MORPHINE; MUSCLE RELAXANT AGENT; NALOXONE; OXOTREMORINE; RESERPINE; SELEGILINE; TETRAZEPAM; TIZANIDINE; TRAMADOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MEASUREMENT; MOTOR ACTIVITY; MUSCLE RIGIDITY; MUSCLE TONE; NONHUMAN; RAT; STRESS; TECHNIQUE; TREMOR;

ANALGESICS, OPIOID; ANIMALS; ANTIPARKINSON AGENTS; CENTRAL NERVOUS SYSTEM DEPRESSANTS; MALE; MUSCARINIC AGONISTS; MUSCLE RELAXANTS, CENTRAL; MUSCLE RIGIDITY; MUSCLE, SKELETAL; MYOGRAPHY; OXOTREMORINE; RATS; RATS, SPRAGUE-DAWLEY; RESERPINE; TAIL; TREMOR;

EID: 0030850509     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Agarwal, S. L., Bose, D., Br. J. Pharmacol. 30, 349 (19671)
2. Ahmed, A., Taylor, N. R. W., Br. J. Pharmacol. 14, 350 (1959)
3. Anderson, R., Acta Neurol. Scand. 58, 584 (1985)
4. Carlsson, A., Lindqvist, M., Magnusson, T., Nature 180, 1200 (1957)
5. Chalmers, R. K., Yim, G. K. W., Proc. Soc. Exp. Biol. Med. 109, 202 (1962)
6. Cho, A. K., Haslett, W. L., Jenden, D. J., J. Pharmacol. Exp. Ther. 138, 249 (1962)
7. Christian, C. M., Waller, J. L., Moldenhauer, C. C., Anesthesiology 58, 275 (1938)
8. Colpaert, F. C., Neuropharmacology 26, 1431 (1987)
9. Coward, D. M., White, T. G., J. Int. Med. Res. 17, 358 (1989)
10. Cox, B., Potkanjak, D., Br. J. Pharmacol. 35, 295 (1969)
11. Fischer, P.-A., Inhibitors of Mono-amino Oxidase B, I. Szelenyi (ed.), p. 51, Birkhäuser Verlag Basel-Boston etc. (1992)
12. Gerhard, J. M., Hong, J. S., Uphouse, L. L. et al., Toxicol. Appl. Pharmacol. 66, 234 (1982)
13. Gothoni, P. Lehtenen, M., Silen, L., Psychopharmacology 74, 275 (1981)
14. Gruenau, S. P., Ackerman, M. J., Biomed. Res. 5, 335 (1978)
15. Hallberg, H., Carlsson, L., Elg, R., J. Pharmacol. Methods 24, 261 (1985)
16. Hallett, M., JAMA 266, 1115 (1991)
17. Havemann, U., Turski, L., Kuschinsky, K., Life Sci. 31, 2319 (1982)
18. Helton, D. R., Modlin, D. L., William, P. D., Arzneim.-Fosch./Drug Res. 42 (II), 885 (1992)
19. Jerussi, T. P., Capacchione, J. F., Benvenga, M. J., Pharmacol. Biochem. Behav. 28, 283 (1987)
20. Johnels, B., Pharmacol. Biochem. Behav. 19, 463 (1983)
21. Johnels, B., Steg, G., Unserstadt, V., Brain Res. 140, 177 (1978)
22. Kelly, D. M., Naylor, R. J., Eur. J. Pharmacol. 27, 14 (1974)
23. Knoll, J., J. Neurol. Transm. 22, 75 (1986)
24. Knowles, W. D., Phillips, M. I., Neuropharmacol. 19, 745 (1980)
25. Kolasiewicz. W., Baran, I., Wolfarth, S., Naunyn-Schmiedeberg's Arch. Pharmacol. 335, 449 (1987)
26. Lorenc-Koci, E., Ossowska, K., Wardas, J. et al., J. Neural-Transm. Parkinson-Dis. Demetia Sect. 9, 211 (1995)
27. Maj, J., Rogoz, Z., Skuza, G. et al., J. Neural. Transm. 80, 129 (1990)
28. Moore, R., Sigg, E. B., Schneider, J. A., J. Appl. Physiol. 11, 488 (1957)
29. Nowack, G. D., Zwolshen, J. M., J. Pharmacol. Methods 10, 175 (1983)
30. Ono, H., Fukuda, H., Kudo, Y., J. Pharm. Dyn. 7, 171 (1984)
31. Ryan, P. M., Kelly, J. P., Leonard, B. E. et al., Toxicol. Lett. 74, 71 (1994)
32. Shinozaki, H., Neurosci. Res. 2, 63 (1984)
33. Simiand, J., Keane, P. E., Biziere, et al., Arch. Int. Pharmacodyn. 297, 272 (1989)
34. Slater, P., Longman, D. A., Drug Dev. Res. Suppl. 1, 153 (1982)
35. Srivastava, V. K., Palit, G., Agarwal, A. K. et al., Indian J. Exp. Biol. 26, 15 (1988)
36. Spencer, P. S., Br. J. Pharmacol. 25, 442 (1965)
37. Tasker, R. R., Sogabe, K. A., Trans. Am. Neurol. Assoc. 98, 240 (1973)
38. Wand. P., Kuschinsky, K., Sontag, K.-H., Eur. J. Pharmacol. 24, 189 (1973)
39. Wolfarth, S., Kolasiewicz, W., Ossowska. K. et al., Naunyn-Schmiedeberg's Arch. Pharmacol. 345, 209 (1992)
40. Yen, H. C. Y., Day, C. A., Arch. Int. Pharmacodyn. Ther. 155, 69 (1965)